Treating the individual: The need for a patient-focused approach to the management of renal cell carcinoma.


Five targeted agents have shown efficacy in advanced renal cell carcinoma. These agents were evaluated in pivotal phase III clinical trials using different treatment settings and different patient populations. As patients encountered in 'real life' clinical practice are frequently under-represented in phase III trials, making treatment decisions based on… (More)
DOI: 10.1016/j.ctrv.2009.09.001


5 Figures and Tables